Are you seeking for broad and meaningful responsibilities in a patient-focused company? Do you want to leave a mark and work in a dynamic and flexible environment? Join Versantis on its ambitious mission to revolutionize the care of patients with liver diseases. You will report directly to the COO and be empowered to design and lead the clinical trials of Versantis’ flagship clinical program - VS-01.
The goal of this position is to advance VS-01 to a mutli-site international POC Phase 2 trial. We are looking for a full-time Senior Clinical Trial Manager with experience in the overall conduct of clinical trials from start to closure, including aspects related to budgeting, data review, reporting, project management, regulatory filings, and compliance to applicable regulations/guidelines.
Eveline Venosta, People Operation Manager, firstname.lastname@example.org, +41 44 500 88 91.
Versantis is a clinical-stage biotech company focused on the development of orphan drugs in liver diseases and pediatric inborn errors of metabolism. Venture capital-backed, Versantis recently closed a CHF 16m Series B financing round to advance clinical development of novel therapeutics for liver diseases. Founded by leading scientists from ETH Zurich and industry experts, Versantis is pursuing innovative therapies for the acute care of serious liver conditions based on its proprietary liposomes-based technology. Versantis has successfully raised private and public capital and was rewarded with prestigious scientific and entrepreneurial prizes (MassChallenge winner, Best Swiss Biotech Startup, Top100 Award, VentureKick, Pfizer Research Award).
Versantis’ lead candidate, VS-01, uses a disruptive approach to effectively treat decompensated cirrhosis (Versantis’ most advanced program) as well as rare pediatric hyperammonemic crisis caused by genetic disorders. VS-01 is about to complete a Ph1b first-in-human trial. It was granted two orphan drug designations in acute liver failure by the EMA and in ACLF by the FDA, which will streamline its clinical development pathway. In parallel, Versantis’ R&D programs continue to grow via close collaborations with Top Research Institutions.